Compound Radar

MiniMed Group, Inc. (MMED) Stock Analysis

Price $23.32
Market cap $6.56B
Next earnings Nov 16, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

62
62/100 Good Quality
  • Financial Health 60
  • Profitability 45
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 60

Why this rating?

Health 62/100 — Good Quality

Strongest Business Quality 75/100
Softest Profitability 45/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

MiniMed Group, Inc. (MMED) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates MiniMed Group, Inc. 62/100 (Good Quality) due to high business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Elevated

Financial highlights

Valuation

  • Forward P/E 35.92
  • EV/Revenue 1.95

Profitability

  • Revenue Growth 16.6%
  • Gross Margin 56.7%
  • Operating Margin 0.2%
  • Net Margin -9.7%

Financial strength

  • Cash $298.00M
  • Debt $53.00M
  • Net Cash $245.00M
  • Free Cash Flow $-420.00M

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks MiniMed Group, Inc. (MMED).

View Methodology & FAQ →